Quaker Chemical Corporation (KWR) Stock Price & Analysis
Quaker Chemical Corporation (KWR) closed at USD 156.56 on Thursday, October 22, 2026, down 0.07% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 156.67; the Oct 22, 2026 session ranged USD 154.77–157.09 on volume of 127,838 shares. Market capitalization is $2.69B, with a 52-week range of USD 112.18–183.01 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 09:24 UTC.
Also available as compact Markdown for AI agents: nexqual.com/KWR.md
Key facts (KWR)
- Last four reported quarters (through Jun 30, 2026): revenue $1.98B, net income $97.7M (4.9% margin), free cash flow $74.6M (SEC filings).
- Valuation: P/E 27.6x (avg 27.8x at the last 2 fiscal year-ends), EV/EBITDA 15.4x, net debt $718M.
- 1 of 80 tracked superinvestors hold KWR (13F, Q2 2026): 0 new, 1 added, 0 reduced, 0 unchanged.
- Insider open-market sales, last ~7 months: 2 Form 4 filings, $208K; 2 not under a Rule 10b5-1 plan ($208K); 0 by opportunistic insiders, 0 by routine insiders (three-year test, Cohen, Malloy & Pomorski 2012).
- Analysts: Buy (mean 1.71 on a 1–5 scale) (7 analysts), mean target USD 193.14 (range 180–202).
- Total return with dividends: 1Y +17.9% vs S&P 500 +14.9%; 5Y -28.9% vs S&P 500 +80.3%.
- Next earnings: 2026-10-29, EPS estimate USD 2.1, revenue estimate $523M.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (KWR)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $1.76B | $1.94B | $1.95B | $1.84B | $1.89B | $1.98B |
| Gross profit | $595M | $613M | $706M | $686M | $679M | — |
| Operating income | $150M | $52.3M | $214M | $195M | $53.0M | $152M |
| Net income | $121M | -$15.9M | $113M | $117M | -$2.5M | $97.7M |
| EPS (diluted) | $6.77 | -$0.89 | $6.26 | $6.51 | -$0.14 | — |
| Free cash flow | $27.5M | $13.3M | $240M | $163M | $80.6M | $74.6M |
| Gross margin | 33.8% | 31.5% | 36.1% | 37.3% | 36.0% | — |
| Operating margin | 8.5% | 2.7% | 11.0% | 10.6% | 2.8% | 7.7% |
| Net margin | 6.9% | -0.8% | 5.8% | 6.3% | -0.1% | 4.9% |
| Revenue growth | +24.2% | +10.4% | +0.5% | -5.8% | +2.7% | — |
| Cash + short-term investments | $165M | $181M | $195M | $189M | $180M | — |
| Total debt | $893M | $953M | $755M | $707M | $871M | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (KWR)
P/E 27.6x · P/S 1.4x · EV/EBITDA 15.4x · EV/Sales 1.7x · P/FCF 36.1x · P/B 2.0x · FCF yield 2.77% · Earnings yield 3.63% · Dividend yield (paid, TTM) 1.29% · Net debt $718M · EV $3.41B
P/E at fiscal year-ends: Dec 2024 21.6x, Dec 2023 33.9x.
Superinvestors (SEC 13F-HR, Q2 2026) (KWR)
1 of 80 tracked investors hold KWR. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| First Eagle Investment | First Eagle Investment Management | 0.04% | $25.9M | Added +72.4% |
Insider sales (SEC Form 4, open-market, last ~7 months) (KWR)
0 of 2 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.
| Trade date | Insider | Role | Shares | Value | % of holdings sold | 10b5-1 plan | Insider type |
|---|---|---|---|---|---|---|---|
| 2026-08-04 | Osborne William H | Director | 600 | $101K | 8% | No | Too little history (no open-market trades in 2023 or 2025) |
| 2026-05-26 | Bijlani Jeewat | EVP, Glob. Spec. & CGO | 731 | $107K | 9.7% | No | Too little history (no open-market trades in 2025) |
% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.
Analysts (KWR)
Consensus Buy (mean 1.71 on a 1–5 scale), 7 analysts; mean target USD 193.14 (low 180, high 202).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-15 | RBC Capital | Target raised | Outperform | $198 → $202 |
| 2026-09-30 | Freedom Capital Markets | Maintained | Buy | $195 |
| 2026-08-25 | Deutsche Bank | Target raised | Buy | $165 → $185 |
| 2026-08-03 | RBC Capital | Target raised | Outperform | $177 → $198 |
| 2026-08-03 | Truist Securities | Target raised | Buy | $172 → $190 |
Total return (dividends reinvested) (KWR)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | +17.9% | -28.9% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +17.9% | -6.6% |
| Volatility (annualized) | 37.3% | 39.0% |
| Max drawdown | -36.5% (Feb 2026→Mar 2026) | -61.0% (Nov 2021→Apr 2025) |
KWR revenue by product line (quarter ended Jun 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| Metalworking and other | $364.3M | 68.4% | +10.9% |
| Metals | $168.2M | 31.6% | +8.6% |
| Total revenue | $532.5M | 100% | — |
KWR revenue by region (quarter ended Jun 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| Americas | $236.5M | 44.4% | +7.0% |
| EMEA | $158.4M | 29.8% | +13.2% |
| Asia/Pacific | $137.6M | 25.8% | +12.4% |
| Total revenue | $532.5M | 100% | — |
As tagged by the company in its SEC 10-Q / 10-K filings (XBRL).
KWR customer concentration
In the period ended Dec 31, 2025, 2 direct customers each accounted for at least 10% (11%, 3%) of revenue, per the company's 10-Q filed Jul 30, 2026. The company does not name them.
KWR company outlook (results filed Jul 30, 2026)
- “I'm proud of our team's ability to maintain reliable supply to our customers despite heightened volatility. 1 Looking ahead, we expect stable demand trends entering the third quarter with flat to slightly positive end markets throughout the remainder of the year.”
- “We anticipate meaningful revenue and adjusted EBITDA growth in 2026 supported by continued share gains, disciplined cost management, and the resilience of our global network." Second Quarter 2026 Segment Results The Company's second quarter of 2026 operating performance for each of its three reportable segments: (i) Americas;”
Quoted word-for-word from the SEC 8-K results press release.
KWR analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $2.10 | $1.95 | +7.6% | $522.9M | 7 |
| Next quarter (ends Dec 2026) | $1.80 | $1.83 | -1.3% | $499.2M | 7 |
| Current fiscal year (ends Dec 2026) | $7.87 | $7.05 | +11.6% | $2.03B | 7 |
| Next fiscal year (ends Dec 2027) | $9.56 | $8.81 | +8.5% | $2.13B | 7 |
Key Statistics (as of October 23, 2026 at 09:24 UTC)
| Price | USD 156.56 |
|---|---|
| Change | ▼ 0.07% (down) |
| Previous Close | USD 156.67 |
| Open | USD 154.77 |
| Day Range | USD 154.77 – 157.09 |
| 52-Week Range | USD 112.18 – 183.01 |
| Volume | 127,838 shares |
| Market Cap | $2.69B |
| Exchange | NYQ |
Technical Analysis (KWR)
Nexqual's technical model rates KWR "STRONG SELL" based on 0 bullish and 5 bearish signals across 127 daily candles, as of October 23, 2026 at 09:24 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 43.95 (neutral) |
| vs SMA50 | Below (USD 160.22) |
| MACD | -0.64 (negative) |
Analyst Ratings (KWR)
Wall Street analysts rate KWR "Buy" based on 7 analysts, with a mean price target of USD 193.14 (range USD 180–202), per Nexqual as of October 23, 2026 at 09:24 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 7 |
| Mean Target | USD 193.14 |
| High Target | USD 202 |
| Low Target | USD 180 |
| Buy / Hold / Sell | 7 / 0 / 0 |
Earnings (KWR)
| Next Earnings Date | 2026-10-29 |
|---|---|
| EPS Estimate | USD 2.1 |
| Revenue Estimate | $522.87M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 2.19 vs est 1.66 ▲ beat |
| 2026-03-31 | USD 1.63 vs est 1.62 ▲ beat |
| 2025-12-31 | USD 1.65 vs est 1.75 ▼ miss |
| 2025-09-30 | USD 2.08 vs est 1.98 ▲ beat |
Source: Nexqual, October 23, 2026 at 09:24 UTC.
Financials & Fundamentals (KWR)
| Total Revenue | $1.98B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +10.20% |
| Gross Margin | +36.06% |
| Operating Margin | +9.13% |
| Profit Margin | +4.95% |
| ROE | +7.17% |
| Debt / Equity | 0.67 |
| Current Ratio | 2.46 |
| Total Cash | $155.19M |
| Total Debt | $923.81M |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | $74.59M (3.8% of revenue) |
Source: Nexqual, October 23, 2026 at 09:24 UTC.
Financial Health Score (KWR)
Nexqual rates Quaker Chemical Corporation's overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 09:24 UTC.
| Growth | Mixed — Revenue +2.7% YoY (annual), slow |
|---|---|
| Profitability | Solid — Gross margin 36%, operating 9% (last 12 months) |
| Balance Sheet | Strong — $155M cash and investments vs $873M debt (Jun 2026, SEC) |
| Cash Flow | Mixed — FCF $75M (last 4 quarters to Jun 2026, SEC), slim 3.8% margin |
| Efficiency | Mixed — ROE 7%, ROA 4.1% |
Ownership (KWR)
| Insider Ownership | +22.16% |
|---|---|
| Institutional Ownership | +92.52% |
| Shares Outstanding | 17.21M |
| Float | 13.37M |
| Short % of Float | +15.40% |
Source: Nexqual, October 23, 2026 at 09:24 UTC.
Leadership (KWR)
Quaker Chemical Corporation is led by Joseph A. Berquist, CEO, President & Director, per Nexqual as of October 23, 2026 at 09:24 UTC.
| CEO, President & Director | Joseph A. Berquist |
|---|---|
| Executive VP, CFO & Principal Accounting Officer | Thomas Coler |
| Director of Communications | Melissa McClain |
| Senior Vice President of Regional Commercial Lead EMEA | Miguel Moreno Hernandez |
| Senior Vice President of Regional Commercial Lead Americas | Renato Carvalho |
Major Backers & Investors (KWR)
Notable institutional backers of Quaker Chemical Corporation include Royce & Associates LP, Wellington Management, Morgan Stanley, according to Nexqual as of October 23, 2026 at 09:24 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Royce & Associates LP | 5% |
| Wellington Management | 3.95% |
| Morgan Stanley | 3.33% |
| Nomura Asset Management International Inc | 2.54% |
| William Blair Investment Management, LLC | 2.44% |
| ROYCE FUND-Royce Premier Fund | 2.35% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 12.26% |
| Vanguard Group | 9.12% |
| Dimensional Fund Advisors | 4.51% |
| State Street | 3.32% |
Source: Nexqual, October 23, 2026 at 09:24 UTC.
From Quaker Chemical Corporation's Latest SEC 10-K Filing (filed 2026-02-23)
Key Strengths & Strategy (as disclosed to the SEC)
- With a robust presence around the world, including operations in over 25 countries, the Company's customers include thousands of the world's most advanced and specialized steel, aluminum, automotive, aerospace, offshore, can, mining, and metalworking companies.
Legal & Regulatory Risks (Item 1A, quoted)
- Changes in tax laws could result in fluctuations in our effective tax rate and have a material effect on our liquidity, financial position and results of operations.
- Failure to comply with the complex global regulatory environment in which we operate could have an adverse impact on our reputation and/or a material adverse effect on our liquidity, financial position and results of operations.
- We are subject to stringent labor and employment laws in the jurisdictions in which we operate, and our relationship with our employees could deteriorate which could adversely impact our operations.
- We may be unable to adequately protect our proprietary rights and trade brands, which may limit our ability to compete in our markets and could adversely affect our liquidity, financial position and results of operations.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BCPC | Balchem Corporation | USD 173.23 | ▲ 1.43% |
| SXT | Sensient Technologies Corporati | USD 130.94 | ▼ 0.95% |
| EMN | Eastman Chemical Company | USD 65.31 | ▲ 2.85% |
| AXTA | Axalta Coating Systems Ltd. | USD 35.05 | ▲ 0.2% |
| NEU | NewMarket Corp | USD 876.33 | ▼ 0.98% |
| ESI | Element Solutions Inc. | USD 33.11 | ▼ 8.89% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:24 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt